AzTrials
AzTrials

Arthropathy of KneeAPTNCT04636190

Triathlon All-Polyethylene Tibia Outcomes Study

A study testing Triathlon All-Polyethylene Tibia Knee in people with Arthropathy of Knee and Replacement, run by Stryker Orthopaedics at 6 sites in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthropathy of Knee, Replacement, Knee Arthritis
What is being tested?
Triathlon All-Polyethylene Tibia Knee
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
204 participants
Where
6 sitesUnited States
Study dates
2 Jul 2021to Oct 2033
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Inclusions:

  • Patient underwent primary TKA and is currently implanted with the Triathlon All-Polyethylene Tibia as well as compatible Stryker femoral and patellar components with no pending revision or removal.
  • Patient has signed an IRB-approved, study specific Informed Patient Consent Form.
  • Patient is a male or non-pregnant female and is 18 years of age or older at the time of study device implantation.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations.

Exclusions:

  • Patient had an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
  • Patient had distant foci of infection which could have caused hematogenous spread to the implant site at time of study device implantation.
  • Patient was skeletally immature at time of study device implantation.
  • Patient has a mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.
  • Patient's bone stock was compromised by disease, infection, or prior implantation which cannot provide adequate support and/or fixation to the prosthesis.
  • Patient had severe instability of the knee joint secondary to the absence of collateral ligament integrity and function.
  • Patient was immunologically suppressed or receiving steroids in excess of normal physiological requirements at the time of surgery (e.g. > 30 days duration of treatment).
  • Patient is a prisoner.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • Musculoskeletal Institute, University of Texas Health Austin

    Austin, Texas, 78712

  • Kaleida Health, Department of Orthopaedic Surgery, Buffalo General Hospital

    Buffalo, New York, 14203

  • Department of Orthopaedic Surgery Cleveland Clinic

    Cleveland, Ohio, 44195

  • Duke University Medical Center

    Durham, North Carolina, 27703

  • Michigan Orthopaedic Center

    Lansing, Michigan, 48910

  • Syracuse Orthopedic Specialists, PC

    Syracuse, New York, 13214

Other trials in United States

About this study

Official title: A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia

The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.

Read the detailed description

This study is a retrospectively enrolled, prospective evaluation of the Triathlon All-Polyethylene Tibia (APT) for patients who meet the eligibility criteria. The enrolled cases will be followed for outcomes measured to 10 years. A modular, Triathlon metal-backed tibia (MBT) and polyethylene insert construct will be used as a historical control.

Being tested
Triathlon All-Polyethylene Tibia Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Triathlon All-Polyethylene Tibia KneeDevice

    Triathlon All-Polyethylene Tibia Knee is an all polyethylene resurfacing knee device using either a condylar stabilizing (CS) and posterior stabilizing (PS) device.

Study groups in NCT04636190
Study groupRoleWhat they receive
Triathlon All-Polyethylene Tibia KneeOtherAll subjects enrolled will have received the Triathlon All-Polyethylene Tibia Knee device.
Receives: Device: Triathlon All-Polyethylene Tibia Knee

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Society Score (KSS) Function

    The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome postoperative.

    Measured: 10-years postoperative

Secondary outcomes (1)
  1. Kaplan-Meier Survival Analysis

    To present 10-year Kaplan-Meier survival analysis for the Triathlon APT

    Measured: 10-years postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2020
  2. Study start2 Jul 2021
  3. Primary completionOct 2033 (estimated)
  4. Study completionOct 2033 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
204 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04636190
Sponsor's protocol ID
104
Acronym
APT
Status last verified
Feb 2026
First submitted
13 Nov 2020
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Triathlon All-Polyethylene Tibia Knee in people with Arthropathy of Knee and Replacement, run by Stryker Orthopaedics at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Society Score (KSS) Function (time frame: 10-years postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Triathlon All-Polyethylene Tibia Outcomes Study | AzTrials